R&D

Advancing Pharmaceutical Excellence Since 2020

Kaifeng Darui Pharmaceutical Co., Ltd., a high-tech enterprise established in 2020, specializes in the R&D, production, and distribution of premium veterinary APIs, food additives, and pharmaceutical intermediates. With a registered capital of ¥27 million and rapid growth (2024 output: ¥60M+, tax contribution: ¥2M+), we combine scientific rigor with sustainable practices to redefine industry standards.

Core R&D Capabilities

1. State-of-the-Art Infrastructure

GMP-Certified Facilities: Designed per China’s Veterinary Drug Production Quality Management norms, featuring:
- D-grade cleanrooms with independent air purification systems
- 700㎡ API production area (synthesis + refining/packaging)
- Advanced equipment: precision distillation units, 150t/d wastewater treatment, RCO exhaust systems

2. Cutting-Edge Analytical Capabilities

Our labs leverage world-class instrumentation for quality assurance:

Chromatography: Shimadzu HPLC, Yichun GC, Fourier-transform IR
Precision Tools: UV-Vis spectrophotometers, electronic analytical balances, stability test chambers

3. Expert-Led Innovation

20+ specialized researchers (20% of workforce), including 2 professors and 4 senior engineers
University collaborations: Henan Academy of Chemical Sciences, Pingdingshan University
Active patent portfolio: 12 utility patents (e.g., bromonitro alcohol yield enhancement systems) + 4 pending

Strategic Industry Leadership

Key Achievements

2023 High-Tech Enterprise Certification (Henan Province)
2022 Innovative SME Award
18 GMP Certificates for veterinary APIs (issued Nov 2024)

Market-Focused Development

Pet Healthcare Solutions: Developing antiparasitics (e.g., albendazole derivatives) and antiviral APIs
Global Expansion: Cost-competitive API exports with rising international recognition
3-Year Roadmap: Targeting ¥100M output by 2025, doubling R&D investment to ¥20M

Sustainable Growth Philosophy

Guided by our motto “Quality for Survival, Talent for Foundation; Science for Growth, Management for Efficiency,” we prioritize:

Green Chemistry: Closed-loop systems for solvent recovery and low-waste synthesis
Talent Cultivation: 70%+ staff with tertiary education in specialized training programs
Community Impact: 2023 “Charitable Enterprise” honoree for social responsibility initiatives

Why Partner with Darui Pharma?

End-to-End Expertise: From molecular design to scaled GMP production
IP-Protected Solutions: Customizable intermediates like brominated alkanes and chlorobenzamide derivatives
Regulatory Mastery: Full compliance with veterinary medicine and food additive regulations

Contact Us to explore API development, technology transfers, or custom synthesis projects.

Kaifeng Darui Pharmaceutical Co., Ltd.

Dedicated to high-end pharmaceutical raw materials, food additives, and intermediates.

About Us

Kaifeng Darui Pharmaceutical Co., Ltd., established on June 19, 2020, with a registered capital of 27 million RMB, is a high-tech enterprise located in the Kaifeng Fine Chemical Industrial Park. We focus on the R&D, production, and sales of high-end pharmaceutical raw materials, food additives, and intermediates.

We are a professional GMP-certified manufacturer of veterinary non-sterile APIs, strictly adhering to veterinary GMP requirements in design and construction. Our facility boasts a clean production environment and a rational layout.

We uphold the concept of green development, emphasizing talent and team building to achieve sustainable and healthy growth.

Financial Highlights:

2023 Total Output Value: 44 million RMB, Tax Contribution: 1.45 million RMB.
2024 Total Output Value: Over 60 million RMB, Tax Contribution: 2 million RMB.

Company Philosophy: "Survive by quality, root in talent; develop by technology, benefit from management." We persistently pursue excellent quality and a perfect brand and corporate image.

Research & Development

Since our inception, we established a dedicated technical team for R&D and technology introduction. Currently, we employ over 100 staff, with more than 20 R&D professionals (over 20% of workforce). Over 70% hold college degrees or higher, including 2 senior engineers, 2 associate professors, 1 lecturer, and 4 intermediate engineers.

We possess an independent R&D center (320 sq meters) with professional chemical laboratories and dedicated testing/analysis units. Our equipment includes HPLC, GC, UV-Vis Spectrophotometers, analytical balances, moisture analyzers, etc.

We collaborate closely with domestic universities and research institutions like Henan Academy of Sciences Chemical Research Institute Co., Ltd., Pingdingshan University, and Xinxiang Medical University to foster industry-university-research cooperation.

Facilities

Our plant is designed and built according to "Veterinary Drug Manufacturing Quality Management Standards".

Non-sterile API workshop (700 sq meters) with synthesis and refining/drying/packaging sections.
Two production lines with separate air purification systems; clean areas meet Class D standards.
Standardized production workshops, distillation equipment, 150 t/d wastewater treatment facility, and RCO exhaust gas treatment unit.
Water production equipment and air conditioning/purification systems.
Warehousing: Raw/auxiliary material, finished product, packaging material, and special management finished product warehouses.

Qualifications & Honors

High-tech Enterprise Certification (2023).
Henan Province Innovative Small and Medium-sized Enterprise (Dec 2022).
Kaifeng City Alkane Bromination Product Engineering Technology Research Center (2023).
Loving Charity Enterprise Title (Jan 2023).
Kaifeng Pharmaceutical Industry Association Council Member (Since 2021), Chairman Yang Xiaoke appointed as Council Director (Jan 2024).
Veterinary Drug Production License and 18 API GMP Certificates from Henan Provincial Department of Agriculture and Rural Affairs (Nov 2024).

Intellectual Property

We emphasize technological innovation and transformation. As of the report date, we hold 12 utility model patents, with 4 applications pending. These patents enhance our independent innovation capabilities and promote the transformation of scientific achievements.

Products & Services / Cooperation

Focus Areas:

Fine Chemicals & APIs
Food Additives
Fine Chemical & Pharmaceutical Intermediates

Areas for Cooperation:

Development of new veterinary and pet APIs.
Development of new food additives.
Cooperation on key production technologies, development and application of fine chemicals and pharmaceutical intermediates.

Future Outlook & Industry Prospects

As a certified High-tech Enterprise, we aim to standardize R&D project management, enhance innovation, and follow the growth path of quality SMEs (Sci-tech SME, Innovative SME, "Specialized, Refined, Unique, New" SME, Sci-tech Little Giant).

Key Development Directions:

Leveraging alkane bromination technology, establishing a national-level R&D, demonstration, training, pilot testing, and cooperation base.
Strengthening high-value-added biomedical fine products based on existing antiviral and anthelmintic products through R&D and university collaborations.
Continuing focus on veterinary APIs, capitalizing on the growing pet market, expanding livestock farming needs, and increasing international competitiveness and export opportunities for Chinese veterinary APIs.

Three-Year Goal (Targeting 2025): Achieve 100 million RMB in production and sales value, increase R&D investment to 20 million RMB, develop 2-3 new products annually, and attain the "Specialized, Refined, Unique, New" enterprise status.